SCHEDULE 13G

Company

Aptose Biosciences Inc.

Filed

April 14, 2014

Accession Number

0000929638-14-000407

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →